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Abstract The ferritin superfamily contains several pro-
tein groups that share a common fold and metal coordi-
nating ligands. The different groups utilize different
dinuclear cofactors to perform a diverse set of reactions.
Several groups use an oxygen-activating di-iron cluster,
while others use di-manganese or heterodinuclear Mn/Fe
cofactors. Given the similar primary ligand preferences of
Mn and Fe as well as the similarities between the binding
sites, the basis for metal specificity in these systems
remains enigmatic. Recent data for the heterodinuclear
cluster show that the protein scaffold per se is capable of
discriminating between Mn and Fe and can assemble the
Mn/Fe center in the absence of any potential assembly
machineries or metal chaperones. Here we review the
current understanding of the assembly of the heterodinu-
clear cofactor in the two different protein groups in which
it has been identified, ribonucleotide reductase R2c pro-
teins and R2-like ligand-binding oxidases. Interestingly,
although the two groups form the same metal cluster they
appear to employ partly different mechanisms to assemble
it. In addition, it seems that both the thermodynamics of
metal binding and the kinetics of oxygen activation play a
role in achieving metal specificity.
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Abbreviations
BMM Bacterial multicomponent monooxygenase
DFT Density functional theory
EPR Electron paramagnetic resonance
R2a Class Ia ribonucleotide reductase R2 subunit
R2c Class Ic ribonucleotide reductase R2 subunit,
used here to refer to the class Ic R2 protein from
Chlamydia trachomatis
R2lox R2-like ligand-binding oxidase, used here to
refer to the R2lox homologue 1 from Geobacillus
kaustophilus
RNR Ribonucleotide reductase
sMMO Soluble methane monooxygenase
XAS X-ray absorption spectroscopy
Introduction
The metal-based cofactors that are utilized by nature range
from the structurally very simple to those with very com-
plex arrangements of metal clusters. In the most basic cases
a single metal ion is coordinated by protein side chains,
such as in the mononuclear non-heme iron enzymes [1].
Many proteins, however, utilize large and/or multiple metal
clusters, such as iron-sulfur cluster proteins [2, 3], the
nitrogenase system [4–7], and cytochrome c oxidase [8, 9].
They may also include other non-protein inorganic or
organic molecules, such as the hydrogenases [10, 11] or
heme [12, 13] and cobalamine proteins [14]. Often metal
cofactors, in particular the more complex ones, require
elaborate synthesis and assembly machineries. These may
consist of numerous proteins that assist in different steps of
cofactor synthesis and assembly [15–17]. Identification and
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characterization of these important machineries is the topic
of intense investigation. On the other hand, many cofactors
can assemble spontaneously in vitro from the apo (metal-
free) protein and metal ions in solution with a varying
degree of efficiency. For many of the less complicated
cofactors, assembly machineries or specific chaperones
have not been identified, and assembly is efficient in vitro
[15, 16]. Though this ability does not exclude the possibility
that assembly machineries contribute to cofactor formation
in vivo [3, 18, 19], it is reasonable to assume that the
assembly process for many of these cofactors, also in vivo,
is founded in basic chemical principles of metal coordina-
tion and binding. In these cases, the protein environment
has to provide both affinity and specificity for the correct
metal to bind from the complex mixture of the cell.
Many transition metal cofactors are utilized for different
types of redox chemistry, commonly following oxygen
activation of the cofactor which generates oxidized metal
site intermediates [15, 16]. From this perspective, cofactor
assembly in these enzymes consists of a two-step process:
first, binding of the correct metal ion in its reduced form in
the metal-binding site of the protein, and second, the
oxygen activation process resulting in the oxidized active
cofactor intermediate that ultimately performs the chem-
istry. As described here, there is evidence suggesting that
these processes are not isolated, but can cooperate to
achieve correct assembly of the metal cofactor.
The ferritin-like superfamily and the heterodinuclear
Mn/Fe cofactor
The ferritin-like superfamily encompasses several groups
of non-heme di-metal carboxylate proteins. In these pro-
teins, the metal ions are coordinated in the center of a
4-helix bundle by four carboxylate and two histidine resi-
dues [20–22]. The 4-helix bundle has a particular topology
that is shared among the protein groups and, although the
sequences have diverged to the point where a common
evolutionary origin between many of the groups is not
detectable by sequence alone, structural homology and the
chemical features of the groups strongly suggest a common
ancestry [23]. The protein scaffold binds two metal ions in
the ?II oxidation state. The metals are then oxidized,
commonly by molecular oxygen, producing an oxidized
cofactor that is used for performing the chemical function
[22–32].
Two of the best-studied groups of the ferritin-like
superfamily are the bacterial multicomponent monooxy-
genases (BMMs) and the ribonucleotide reductase (RNR)
R2 proteins. BMMs use an oxidized di-iron cofactor to
perform very challenging two-electron oxidations. For
example, the soluble methane monooxygenase (sMMO)
utilizes an oxo-bridged FeIV/FeIV intermediate to activate
the strongest C–H bond of any saturated hydrocarbon,
hydroxylating methane to methanol [31, 33, 34].
Ribonucleotide reductases are the only identified
enzyme systems for de novo synthesis of all four deoxy-
ribonucleotides, thus producing the building blocks of
DNA [35, 36]. Class I RNR is found in eukaryotes, eu-
bacteria, and a few archaea and consists of two protein
subunits, the catalytic R1 subunit and the R2 subunit which
generates and provides a radical to the R1 subunit, essential
for activity in all RNRs [37]. The R2 proteins are further
subdivided into three classes: Ia, Ib, and Ic, depending on
allosteric properties and the nature of the metal cofactor
and radical species [35, 37, 38]. Chemically, the R2 pro-
teins differ from BMMs in that they perform a one-electron
oxidation (radical generation) compared to the two-elec-
tron oxidations performed by BMMs. Reduction of
molecular oxygen requires four electrons. If these are all
taken from the metal ions, both ions are oxidized from the
?II to the ?IV oxidation state. This FeIV/FeIV state is the
catalytic intermediate of sMMO [34]. In class Ia R2 pro-
teins, on the other hand, an external electron is injected
during the oxygen activation reaction, resulting in an FeIII/
FeIV oxidation state. This intermediate, denoted interme-
diate X, oxidizes a nearby tyrosine to a tyrosyl radical
which serves as the radical storage site before it is
(reversibly) delivered to the substrate-binding R1 subunit
for use in catalysis [37, 39, 40]. The class Ib R2 proteins
can function with a di-iron site by direct activation of
molecular oxygen in a fashion analogous to the class Ia
proteins [41, 42]. Interestingly, however, the class Ib pro-
teins also function as di-manganese proteins, but then
requiring an additional flavodoxin subunit, NrdI, to provide
the oxidant for the metal site. Recent evidence suggests
that NrdI utilizes molecular oxygen to produce a super-
oxide species which is funneled to the reduced di-manga-
nese site and oxidizes it to a III/IV oxidation state that
subsequently generates the tyrosyl radical [27, 43–45].
Which cofactor, di-iron or di-manganese, is used chiefly
in vivo may differ between species and conditions. There is
evidence that the Bacillus subtilis and Corynebacterium
ammoniagenes class Ib R2 proteins are di-manganese
enzymes when purified from the native organism, even
when overexpressed at non-native levels [46–48] and that
the Escherichia coli class Ib R2 protein forms a di-man-
ganese site at native expression levels in an Fe-uptake
deficient strain grown under Fe-limiting conditions [49].
The discovery of the heterodinuclear Mn/Fe cofactor
began with the cloning of the R2 gene from the human
pathogen Chlamydia trachomatis. The protein showed
activity in vitro, despite the fact that the sequence appeared
to lack the otherwise essential radical harboring tyrosine
residue [50]. The structure of the protein was solved in
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2004, confirming the lack of the radical harboring amino
acid [51]. Using bioinformatics methods, a number of other
R2 proteins that shared this feature were also identified
[51]. It was proposed that the tyrosyl radical was replaced
by a high-valent form of the metal cluster as the repository
for the oxidizing equivalent needed to initiate ribonucleo-
tide reduction, and this new R2 subclass was denoted class
Ic [51]. In 2007, it was shown that the activity of the
protein was greatly enhanced in the presence of manganese
and that the metal site responsible for this activity was a
heterodinuclear Mn/Fe cluster [52, 53]. Subsequently, it
was demonstrated that the protein group to which the C.
trachomatis class Ic R2 protein belongs actually consists of
two groups of proteins, the R2 proteins and a group of
ligand-binding oxidases also forming a heterodinuclear
Mn/Fe center, denoted R2-like ligand-binding oxidases
(R2lox) [24]. This study also described the structure of the
heterodinuclear cluster in the R2lox protein from Myco-
bacterium tuberculosis. The structure revealed that metal
binding is specific, with the Mn ion occupying metal
position 1 (the N-terminal metal-binding site) and Fe in
metal position 2 (Fig. 1). The structure of the Mn/Fe
cluster in the C. trachomatis class Ic R2 protein (hereafter
denoted R2c) was also recently determined, showing the
same metal positioning as the M. tuberculosis R2lox [54–
56]. The two groups of proteins containing the Mn/Fe
cluster were further described in a bioinformatics study
based on available sequences in the databases [57]. In
2010, around 50 sequences each could be assigned to these
two groups. With continuing sequencing efforts these
numbers have now grown to over 250 R2lox and 150 R2
sequences lacking the radical harboring tyrosine available
in GenBank [58].
Metal binding and the basis for metal specificity
in di-metal carboxylate proteins
The metal-binding sites in most di-metal carboxylate pro-
teins are comprised of two histidines and four carboxylate
residues. This coordination sphere is the same for all three
types of metal sites, illustrating the challenges in a priori
assignment of metal centers based on sequence or structure.
In BMMs as well as both groups of Mn/Fe proteins all four
carboxylates are glutamate residues. In the class Ia and
class Ib R2 proteins, on the other hand, the first carboxylate
ligand in the primary sequence is an aspartate (Fig. 1). The
ligands bind two metal ions to form a dinuclear metal
center that is commonly of a (distorted) octahedral geom-
etry, though there are exceptions [59]. During the oxygen
activation reaction, a number of the carboxylate ligands
move and change their coordination mode and the number
of metal contacts (so-called carboxylate shifts) [31, 59–62].
Mn and Fe are neighbors in the periodic table and can be
isoelectronic depending on oxidation state. Their primary
ligand and coordination geometry preferences are, there-
fore, qualitatively similar, thereby complicating direct
discrimination between the two metals in a protein binding-
site. Nevertheless, there are quantitative differences in their
interactions with coordinating ligands that result in differ-
ences in the stability of complexes. A convenient way of
describing these differences was introduced by Irving and
Williams [63]. They found that the stability of complexes
of divalent ions of first-row transition metals followed the
order MnII \ FeII \ CoII \ NiII \ CuII [ ZnII, in essence
regardless of the nature of the coordinating ligand. This
relationship is commonly called the Irving–Williams ser-
ies. The behavior can be rationalized based on the trends in
ionic radii and crystal field stabilization energy of the
metals. CuII represents a special case as it is subject to a
strong Jahn–Teller effect (see below) which provides fur-
ther stabilization of the complex.
The Jahn–Teller theorem in principle predicts that
complexes with a degenerate ground state will undergo
distortion of the geometry to remove this degeneracy,
resulting in a lowering of the energy and stabilization of the
complex [64, 65]. For octahedral complexes this usually
leads to an elongation of the coordination distances along
one of the axes. If the degenerate orbitals point directly
toward the ligand, the distortion and stabilization is sig-
nificantly stronger than otherwise. For high-spin octahedral
complexes of Mn and Fe, no Jahn–Teller effect is expected
for FeIII and MnII, whereas a strong effect is present for
MnIII and, in principle, a weak effect for FeII.
While the Irving–Williams series description is attrac-
tive and serves well to describe many observations
regarding protein metallation, it cannot easily be applied to
biological systems in the cellular context. The concentra-
tion of free metal ions in a living cell is very low, and for
many metals it is expected to be effectively zero. In vivo,
metal ions mainly exist in complex with other ligands, and
thus the absolute stability of a complex is less important
than the relative stability of the protein–metal complex as
compared to the complex between the metal and the ori-
ginal ligands which are released upon metal binding to the
protein [15]. Moreover, the behavior predicted by the
Irving–Williams series does not help us in understanding
the selection of Mn over Fe, as it predicts that Fe would
always form a more stable complex than Mn.
The Jahn–Teller effect, on the other hand, could in
principle be utilized to tune metal specificity between Mn
and Fe. For example, if the metal ions, before binding to
the protein, are bound by ligands that adapt to the Jahn–
Teller distortion of FeII, while the protein enforces a strict
octahedral coordination, it would be expected that FeII
would be less prone to bind there, compared to a more
J Biol Inorg Chem (2014) 19:759–774 761
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flexible site. This situation would, therefore, in principle
increase the MnII to FeII ratio in that site. However, the
Jahn–Teller effect for FeII is weak, and metal-coordinating
side chains in proteins commonly show a flexibility that
would be expected to accommodate these differences.
Thus, this effect is unlikely to provide a significant con-
tribution to specificity in practice.
Compared to some of the very complex cofactors
mentioned above, assembly of the Mn/Fe cofactor dis-
cussed here may appear deceivingly simple at first glance
because it consists of just two metal ions coordinated
directly by the protein matrix. However, the case appears
much more complicated when one considers that the two
ions are bound by identical protein ligands, provided in a
symmetric fashion by the protein, but nonetheless Mn is
found in one site, while the other binds Fe. In addition, the
proteins and metal-binding sites that house this heterodi-
nuclear cofactor are very similar to a number of well-
studied protein groups that form di-iron centers. Even from
high-resolution structures of members of the different
families, it is not apparent which proteins will form which
particular type of site (Fig. 1). In this case, metal speci-
ficity is thus the fundamental problem that must be solved
for the cofactor to form correctly. Metal chaperones that
specifically deliver metals can be used for these purposes
[66–68], in essence transforming a metal-coordination
specificity problem to an, arguably simpler, protein–protein
interaction specificity problem. Of course, the chaperone
itself must also acquire the correct metal by some means.
Utilizing different folding compartments with different
metal content can also be used to control protein metalla-
tion [18, 69]. However, recent studies show that the hete-
rodinuclear Mn/Fe cofactor can be assembled in vitro in the
absence of any potential assembly machineries or chaper-
ones [28, 56]. This observation is consistent with the
finding that the cofactor can be assembled when proteins
are heterologously expressed in E. coli [24, 54, 70]. In
these cases, the protein scaffold per se is thus able to direct
metallation and discriminate between Fe and Mn in the
different positions.
The need for specificity and technical considerations
Metal binding to a protein is ultimately an equilibrium
reaction. Although a protein in its native state typically
functions with only one type of metal ion, it usually has
affinity for other cations in the same chelating position.
Thus, if the apo protein is produced and exposed to a
sufficient concentration of a different metal, this will
generally bind in the same metal-binding site [18, 61, 71–
73]. For this reason, exposure of an apo protein to a mix-
ture of metals at different concentrations, as in the living
cell, will generally result in a population of proteins with
different metals bound. There is usually only one type of
metal that provides the activity required for a metallopro-
tein to be able to fulfill its physiological function. It is thus
advantageous for the organism to have a large fraction of
the protein population acquire this particular metal, as most
other complexes are likely inactive and would be a waste of
energy and resources to produce. However, as long as the
function can be fulfilled at an acceptable metabolic cost,
having subpopulations of mismetallated proteins does not
pose a major problem. In some instances, it may even be
advantageous for the evolution of new functions or capa-
bilities [18, 30, 73, 74]. The different metal requirements of
the different proteins in the ferritin superfamily are likely a
result of these evolutionary principles [23].
The conditions in vivo differ from those commonly used
to study metalloproteins. Available spectroscopic and
crystallographic methods require large amounts of a highly
purified and homogeneous sample. Usually, the protein is
obtained by heterologous overproduction, a situation that
may be very distant from the native environment regarding
metal availability, competing proteins, and cofactor
assembly machineries [73, 75]. In vitro cofactor assembly
cFig. 1 Crystal structures of di-metal-carboxylate proteins with dif-
ferent metal specificities in the oxidized, reduced, and metal-free
state. Carbon atoms of metal-coordinating residues are colored cyan,
those of exogenous ligands light blue (oxygen and nitrogen are
colored red and blue, respectively). Fe and Mn are shown as orange
and purple spheres, respectively, and water/oxo/hydroxo ligands as
smaller red spheres. Metal–ligand bonds are indicated by gray lines.
All structures are oriented with site 1 on the left, and the metal-free
state is always shown superimposed with the reduced metal-bound
state in transparent gray. Geobacillus kaustophilus R2lox homologue
1 (GkR2loxI) binds an exogenous fatty acid ligand. In the oxidized
state (4HR0 [28]) it contains a Mn/Fe center, while in the reduced
state (4HR4 [28]) site 1 is equally occupied by Mn and Fe (modeled
as Mn), and site 2 by Fe. In the metal-free state (4HR5 [28]), site 1 is
disordered, whereas site 2 is largely preformed. A structure of the C.
trachomatis class Ic R2 protein (CtR2c) in the oxidized state is only
available with a di-iron cluster (SYY [51]), while in the reduced state
exclusive occupancy of a Mn/Fe center was obtained (4M1I [56]).
Both sites are ordered in the absence of metal ions (4M1H [56]). The
E. coli class Ia R2 protein (EcR2a) is active with a di-iron cofactor
(oxidized state: 1MXR [124], reduced state: 1XIK [59], metal-free
state [125] ). Class Ib R2 proteins likely utilize a di-manganese
cofactor in vivo [44, 46–49], but are also functional with a di-iron
cofactor [42] and display interesting carboxylate shifts with the
different cofactors as well as between species [27]. Shown is the
Corynebacterium ammoniagenes class Ib R2 protein (CaR2F) in the
oxidized (3 MJO [46]) and reduced (1KGP [41]) Mn/Mn and oxidized
(1KGN [41]) and reduced (1KGO [41]) Fe/Fe-bound, as well as the
metal-free state (3DHZ [126]). Methylococcus capsulatus (Bath)
methane monooxygenase hydroxylase (McMMOH) is a representa-
tive member of the BMM group of di-metal-carboxylate proteins that
utilize a di-iron cofactor (oxidized state with a formate ligand: 1FZ1
[122], reduced state: 1FYZ [122], metal-free state 1XMG [127]).
Note that the most N-terminal metal ligand is an aspartate in class Ia
and Ib R2 proteins, but a glutamate in class Ic R2, R2lox and BMMs
762 J Biol Inorg Chem (2014) 19:759–774
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protocols are also biased by initial assumptions on what
components make up the active metalloprotein. How
cofactor assembly is performed in vitro directly influences
metallation. For the heterodinuclear cofactor discussed
here, sequential addition of metals under different condi-
tions is sometimes required to obtain a large fraction of
correctly assembled centers in the sample for further
studies. No matter what approaches are taken during
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in vitro reconstitution or heterologous production, the
conditions will, in various ways, differ from those for the
assembly of the protein in the native organism at native
expression levels. Understanding cofactor assembly and
specificity thus necessarily includes piecing together
information from different approaches.
Metal ions in a protein sample can be identified and
quantified in many different ways, including inductively
coupled plasma mass spectrometry (ICP-MS), total reflec-
tion X-ray fluorescence (TXRF), proton-induced X-ray
emission (microPIXE) [76], and in many cases using spe-
cific colorimetric reagents. While these methods allow
quantitative determination of the metal content, they do not
reveal the location of the metal ions in the protein.
Protein X-ray crystallography is an extremely powerful
method that provides a global view of relative atomic
positions in a protein and a metal cofactor at atomic res-
olution [77]. For this reason the method commonly serves
as a basis for structural assignment of a cofactor and the
mapping of spectroscopic data. Considering the discussion
regarding specificity and mismetallation above, however,
this method has a general weakness. In a standard crys-
tallographic experiment an electron density map is gener-
ated, describing the distribution of electrons in space. This
is then interpreted as the protein and any other species
bound to it. Atomic assignment of the protein is greatly
simplified because we have a priori knowledge of the pri-
mary structure, i.e., the amino acid sequence and the
chemical structures of the amino acids. Assignment of
bound molecules is more difficult, however, especially for
monoatomic species like metals. As metals have a large
number of electrons and, therefore, result in a relatively
large peak of electron density, their position can be accu-
rately determined. The identity of the metal, on the other
hand, is more difficult to establish. In practice, it is usually
impossible to differentiate between atoms with a similar
number of electrons, such as first-row transition metals. In
addition, the electron density represents an average of
billions of protein molecules in the crystal, and the
resulting peak of electron density will reveal no, or very
little, information about subpopulations of different metals
bound in the same site. This limitation of the method
should be considered when assigning crystallographic data
and interpreting deposited models in the protein data bank
(PDB) [78].
With X-rays of tunable wavelength, however, advantage
can be taken of the fact that atoms absorb X-rays and
display absorption edges at specific X-ray energies that are
characteristic for each element (Fig. 2). This absorption
has a measurable effect on X-ray diffraction data collected
at an element’s absorption edge, termed anomalous dis-
persion or anomalous scattering. From data collected at
absorption edges anomalous difference electron density
maps can be generated in which not only the location, but
also the identity and even relative amounts of different
metal ions in a given position can be determined [24, 28,
54–56, 79]. This is a method that has proven central to
studying the assembly of the heterodinuclear Mn/Fe
cluster.
However, X-ray crystallography alone does not suffice
to fully characterize a metalloprotein’s active site. Using
anomalous dispersion, we can clearly locate, identify, and
even quantify metal ions, but their redox state remains
unknown. Moreover, metal centers in crystals can suffer
photoreduction in the X-ray beam [41, 59, 80–87]. Crystals
are commonly exposed to X-rays at cryogenic temperature
where the extent of movement of the metal ions, coordi-
nating side chains, and other ligands upon photoreduction
is greatly reduced, but from the structures alone it is usu-
ally impossible to tell how much has changed due to
photoreduction. Furthermore, short-lived intermediates are
often difficult to trap crystallographically. Therefore, other
methods are necessary to complete the picture. Most
Fig. 2 X-ray anomalous scattering. The absorption of X-rays by an
element in a crystal has a measurable effect on X-ray diffraction data
collected at that element’s absorption edge, termed anomalous
scattering or anomalous dispersion. This effect can be visualized in
anomalous difference electron density maps. The absorption edges of
most elements in proteins are not accessible by synchrotron radiation,
but the edges of transition metals which commonly make up
metallocofactors are. The graph shows the dispersion, or real (f0)
and absorption, or imaginary (f00) component of the anomalous
scattering of X-rays by Mn, Fe, Cu, and Zn. The imaginary
component f00 is proportional to the absorption curve of the element,
and the real part f0 is mathematically derived from f00 [77]. The insets
show the anomalous difference density from diffraction data collected
at the Mn (pink) and Fe (orange) edges on crystals of metal-free G.
kaustophilus R2loxI soaked with MnII and FeII in the presence of
oxygen, contoured at 4 electrons/A˚3 [28]. At the Mn edge, only Mn
displays an anomalous signal, but at the Fe edge there is also
considerable signal from Mn. To differentiate between Mn and Fe
data therefore have to be collected at both edges, and the Mn
contribution subtracted from the Fe contribution [28, 54–56, 79].
Graph adapted from http://skuld.bmsc.washington.edu/scatter/AS_
index.html
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central to the study of metalloproteins are the different
spectroscopies that specifically visualize the metal clusters:
electron paramagnetic resonance (EPR) [88], X-ray
absorption (XAS) [89], and Mo¨ssbauer spectroscopy [90].
All these techniques reveal information about the redox
state, as well as the electronic environment of the metal
ions. EPR detects unpaired electrons in a sample by their
absorption of microwave energy in a strong magnetic field.
Most elements present in biological molecules contain only
paired electrons, with the notable exception of radicals and
transition metal ions. Therefore, metal centers can be
specifically detected by EPR, given that they are present in
a redox state that contains unpaired electrons. Mo¨ssbauer
spectroscopy is (commonly) limited to samples containing
the iron isotope 57Fe, so Fe cofactors have to be labeled to
be studied. To address the kinetics of metallocofactor-
catalyzed reactions, EPR and Mo¨ssbauer spectroscopy can
be performed in freeze-quench mode. These are very
sample-intense techniques, however, and interesting reac-
tion intermediates are, therefore, generally first identified
using time-resolved UV/visible or resonance Raman
spectroscopy. In addition, computational studies using
density functional theory (DFT) models derived from high-
resolution structures can greatly aid and extend the inter-
pretation of spectroscopic data.
Assembly of the Mn/Fe cofactor
To date, three Mn/Fe proteins have been studied experi-
mentally: the C. trachomatis R2c as well as the R2lox
protein from M. tuberculosis and one of the two R2lox
proteins (termed homologue 1) from Geobacillus kausto-
philus.1 All three proteins were found to bind a heterodi-
nuclear Mn/Fe cluster with the Mn ion in site 1 [24, 28, 52–
56]. However, recent work suggests that R2c and R2lox
proteins may employ partly different mechanisms to
assemble the heterodinuclear cluster [28, 56]. Although
caution must be taken in directly comparing the results of
these studies because different reconstitution protocols
were employed, some differences between the two systems
can be identified.
The Mn/Fe cofactor is assembled in at least two steps. In
the first step, metal ions in the ?II oxidation state bind to
the protein active site. Then, oxygen binds and is reduced.
In this oxygen activation reaction both metal ions are, at
least temporarily, oxidized to the ?IV state. In R2c, an
external electron is subsequently injected, leading to the
active MnIV/FeIII state [52, 91]. The presumed active state
of R2lox proteins is the MnIV/FeIV state. This oxidation
state has to date not been directly observed in the R2lox
proteins, but its existence is postulated because of the
similarity to the R2c system and a number of other
observations: oxygen exposure of the MnII/FeII site in
R2lox results in the formation of a crosslink between a
tyrosine and a nearby valine, a two-electron oxidation.
Computation suggests that the MnIV/FeIV state is capable
of performing the observed chemistry [28]. The reaction
with oxygen also results in the resting MnIII/FeIII oxidation
state of the cofactor, thus, together with the crosslink for-
mation, accounting for all four electrons required for
reduction of molecular oxygen.
How the cofactor is assembled and which metal ions are
eventually found in the active site may depend on a number
of factors. Even if a potential contribution of metallo-
chaperones is excluded, following the equilibrium discus-
sion above, the resulting metal content will be influenced
by which metal ions are available in which concentrations,
both absolute and relative to each other, how specific each
site is for which metal, and what, if anything, happens
during oxygen activation. Is metal selection controlled
thermodynamically or kinetically, or do both thermody-
namic and kinetic effects play a role? Below we summarize
the current understanding of these processes.
Binding of metal ions
R2c and R2lox appear to have different metal preferences
in the reduced state. Fe can bind to both metal sites in both
systems. Because Fe is much more abundant than Mn in
standard E. coli growth media [92], R2c was, therefore,
first isolated with a di-iron cofactor [51, 93], and it took
several years until it became clear that the highest activity
was obtained with a 1:1 ratio of FeII to MnII, suggesting a
heterodinuclear cofactor in the protein [52, 53]. R2lox, on
the other hand, appears to be less prone to form a ho-
modinuclear Fe/Fe site, as the M. tuberculosis protein
overexpressed in E. coli in rich medium still contained a
significant amount of the heterodinuclear cofactor [24].
The fact that Fe readily binds to both sites of R2c and
R2lox also presents researchers with considerable difficulty
in obtaining homogeneous preparations of the mixed-metal
cofactor. From the many different reconstitution protocols
that have been tested it is, however, also possible to learn
much about the cofactor assembly pathway.
Crystal soaking experiments showed that the two metal-
binding sites of R2lox have intrinsically different affinities
for either metal. When exposed to a large excess of MnII and
FeII in equal concentrations in the absence of oxygen, site 2
preferentially binds Fe, as expected based on the Irving–
Williams series. In contrast, site 1 binds equal amounts of Mn
and Fe [28]. This direct competition experiment has not been
1 The term R2lox will hereafter be used to refer to the R2lox
homologue 1 from G. kaustophilus unless otherwise specified.
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performed on R2c, but the site-specific metal content was
analyzed following a sequential metal loading scheme. The
protein was first exposed to 1 equivalent (per protomer) of
MnII, and after introduction into an anaerobic chamber 1
equivalent of FeII was added. Protein crystals obtained from
this mixture contained only Mn in site 1 and only Fe in site 2
[56]. Judging from these results, it appears that site 2 strongly
prefers Fe in both R2c and R2lox, whereas site 1 is non-
specific in R2lox, but prefers Mn over Fe in R2c.
Other experiments shed some more light on the different
metal-binding behavior of the two systems. As discussed
above, if only one type of metal ion is available in very high
concentrations it is likely to bind to both metal sites [18, 41,
61, 73]. However, such experiments are very distant from
metal-binding conditions in vivo. If R2c is incubated with
substoichiometric amounts of Mn only, Mn binds in both or
either of the two metal-binding sites of R2c [56]. (From
these crystallographic experiments it is impossible to tell
whether the observed anomalous difference density for Mn
in both sites stems from simultaneous or alternate occupa-
tion of the two sites, or a mixture of these in the crystal.)
Exposure to excess Mn during cocrystallization or crystal
soaking leads to a maximum occupancy of 90 % Mn in site
2 and 70 % in site 1 [56]. In contrast, Mn does not bind in
any significant amount in site 2 of R2lox. In fact, on its own,
Mn only binds weakly and transiently even in site 1 of
R2lox [28]. It should be noted, however, that the different
reconstitution protocols employed might have influenced
the results obtained: Mn was observed in both sites of R2c
after cocrystallization or crystal soaking with Mn [56]. Mn-
only samples of R2lox were prepared using a fourfold molar
excess of Mn over polypeptide chains, and since these
samples were prepared for EPR analysis, the preparation
included a purification step to remove excess MnII [28].
This step could also remove labile bound MnII from the
protein. It cannot be excluded that this procedure would
have given a similar result for R2c.
Nevertheless, the protocols used to reconstitute the
activated Mn/Fe cofactor in R2c and R2lox indicate that
the two metal-binding sites do exhibit different preferences
for Mn in the two systems. Mn has not been observed in
site 2 of R2lox when reconstituted at a protein:Mn:Fe ratio
of 1:2:1, whereas both Mn/Fe and Fe/Mn centers (but not
Mn/Mn centers) are formed in R2c at similar pro-
tein:Mn:Fe ratios [28, 55]. Several slightly different pro-
tocols have been used to reconstitute the MnIV/FeIII
cofactor in R2c, but in most of them a slight excess of Mn
is added to the protein first, followed by addition of sub-
stoichiometric amounts of Fe in the presence of oxygen.
These procedures typically yield 90 % mixed-metal and
10 % di-iron cofactors [55, 94]. In contrast, when Mn is
added first to R2lox, only *5 % of Mn/Fe cofactors are
obtained (our unpublished data).
It is interesting to note that the observed differences in
metal specificity between R2c and R2lox also relate to
structural differences: site 2 is preformed in the apo protein
in both R2c and R2lox, and no major conformational
rearrangement is required to accommodate the Fe ion [28,
56]. In contrast, site 1 behaves differently in the two sys-
tems. While in R2c site 1 is also ordered in the metal-free
state [56], in R2lox it is disordered [28]. Together with the
observations from different reconstitution schemes, this
indicates that in R2lox Fe has to bind first in site 2, fol-
lowed by binding of Mn or Fe in site 1, suggesting that
metal binding is cooperative. In contrast, metal binding in
R2c was proposed to be non-cooperative [56], but hard
evidence for either suggestion is not available at this point.
If only Mn is present, it binds in site 1 of R2lox and
appears to thereby inhibit binding of Fe added later (but is
then lost during purification). In R2c, on the other hand, Mn
binds in both sites or either site, and when Fe is then added
later (in the absence of oxygen), Mn/Fe cofactors are
formed with high efficiency. A possible interpretation of
these data is that in R2c the main driving force for formation
of the Mn/Fe cofactor is the preference of Fe for site 2,
rather than a preference of Mn for site 1 [56] (Fig. 3). If this
is the case, the Mn/Fe cofactor in R2c will only be effi-
ciently assembled if Fe is substoichiometric, and if oxygen
is excluded until equilibrium has been reached, as both Mn/
Fe and Fe/Fe centers (but not Mn/Mn centers) react with
oxygen and are thereby ‘‘trapped’’ [44, 95, 96].
These models are derived from different experimental
procedures, making direct comparisons difficult. Never-
theless, currently available data do allow the conclusion
that metal binding proceeds via different pathways in R2c
and R2lox, although the presently proposed models
undoubtedly will be refined in the future.
Cofactor activation
As a background to oxygen activation by the heterodinu-
clear Mn/Fe cofactor, it is of use to first briefly describe the
reaction and intermediates in the extensively studied di-
iron cofactor of the class Ia RNR R2 protein (R2a).
In R2a, reduction and cleavage of molecular oxygen
eventually lead to formation of a stable tyrosyl radical (Y)
(Fig. 4). The reaction can be formally written as
R2TyrOH þ ðFe2þFe2þÞ þ O2 þ Hþ þ e
! R2TyrO þ ðFe3þO2Fe3þÞ þ H2O
The radical that resides on the tyrosyl residue in the R2
subunit (Y122 in E. coli R2a) is reversibly transferred via a
defined radical transfer/translocation/hole translocation
pathway to a conserved cysteine residue in the active site of
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the RNR R1 subunit. The resulting cysteinyl radical then
initiates the radical-based substrate reduction mechanism
[37, 38, 97, 98].
Oxygen activation by the reduced, carboxylate bridged
Fe2
II/II metal center in R2a proteins proceeds via a di-ferric
peroxo intermediate, observed in E. coli R2a mutants, and
also in the wild-type R2a from mouse [99–102]. The
complete reduction of molecular oxygen results in the key
intermediate ‘‘X’’, directly preceding the tyrosyl radical. At
this stage the metal site is in the FeIII/FeIV state. The fourth
electron required for complete oxygen reduction is initially
supplied by a near surface tryptophan residue (W48 in
E. coli R2a) that is transiently oxidized to a tryptophan
cation radical [38, 98, 103, 104]. The tryptophan radical is
rapidly reduced by an external reductant. Intermediate X
goes on to oxidize the nearby tyrosine, forming the active
state of the protein with a l-oxo-bridged diferric site and a
tyrosyl radical [32, 39]. Intermediate X has been exten-
sively studied spectroscopically and computationally.
Mo¨ssbauer and 57Fe-ENDOR experiments show a
STotal = 1/2 ground state as the net result of antiferro-
magnetic coupling between FeIII (S = 5/2) and FeIV
(S = 2) at the metal center [105]. Structurally it is char-
acterized as a bis-l-oxo-Fe2
III/IV or l-oxo-l-hydroxo-Fe2
III/
IV site with a coordinated hydroxide, although the details of
the structure are still under debate [39, 60, 105–112].
In class Ic, on the other hand, the reduced MnII/FeII
metal center initially provides all four electrons required
for complete O2 reduction, resulting in a Mn
IV/FeIV inter-
mediate [113]. This intermediate, detected by a combina-
tion of EPR and Mo¨ssbauer spectroscopy, shows a
STotal = 1/2 ground state resulting from antiferromagnetic
coupling between MnIV (S = 3/2) and FeIV (S = 2) at the
metal center [113]. The MnIV/FeIV intermediate has been
suggested to have a bis-l-oxo diamond core structure, in
analogy to the FeIV/FeIV intermediate Q found in sMMO
[34, 114]. The MnIV/FeIV intermediate is formed first-order
based on oxygen concentration and no potential preceding
intermediates, such as the peroxo species in R2a proteins,
accumulate during the reaction [113, 114]. Oxygen is
thought to first add to the metal ion in site 2 in all three
classes of R2 (Fig. 1) [27, 46, 56, 60, 62, 115, 116].
Because an analogous peroxo intermediate to R2a has not
been observed in R2c, it was proposed that addition of O2
to the Fe ion might yield a MnII/FeIII-g2-superoxo complex
from which the MnII could attack the dioxygen bond and
immediately generate the observed MnIV/FeIV intermediate
[56]. This should be possible due to the unusually short
3.2 A˚ distance between the two metal ions in reduced R2c
[56]. It should be noted that the metal ions in reduced
R2lox are at a distance of 3.6 A˚ [28]. However, this
structure represents a mixed occupation of Mn and Fe in
Fig. 3 Models for cofactor assembly and maturation in R2c and
R2lox proteins. The model for R2c is derived from a sequential
loading scheme [56]. When the protein is incubated with MnII alone,
MnII will bind in either site 1 or site 2 with roughly equal probability.
Subsequent addition of FeII in the absence of oxygen leads to FeII
binding in site 2, thereby displacing any MnII ions bound in site 2 to
site 1 (State B). The heterodinuclear cluster thus assembled then
reacts with oxygen and forms the catalytically active MnIV/FeIII state
upon concomitant injection of an external electron. In R2lox, when
exposed to equal concentrations of MnII and FeII simultaneously, site
2 is filled with FeII, and site 1 has approximately equal probability of
binding either a MnII or FeII ion [28]. The protein-bound metal ion is
in equilibrium with solvated metal ions in solution. Subsequent
reaction with O2 generates the putative catalytically active IV/IV
state. The exchange of the reduced ion in site 1 with ions in solution,
combined with a significantly faster reaction of the heterodinuclear
(Mn/Fe) center with O2 compared to that of the homodinuclear (Fe/
Fe) center [96], results in accumulation of the oxidized Mn/Fe
cofactor over the Fe/Fe cofactor. Note that this model predicts
cofactor identity to be influenced by the concentrations of MnII and
FeII in solution due to their impact on the kinetics of metal exchange
J Biol Inorg Chem (2014) 19:759–774 767
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site 1, and we cannot rule out that a shorter distance would
be observed if site 1 was exclusively occupied by Mn.
Conversely, theoretical modeling of the oxygen activation
reaction suggests that molecular oxygen is cleaved by the
reduced Mn/Fe metal center, forming a diamond-shaped
MnIII/FeIII peroxo complex. MnIII is the only redox active
species in the transition state and is oxidized to MnIV,
leading to the homolytic cleavage of the dioxygen bond in
a symmetric diamond-shaped transition state. This is fol-
lowed by immediate transfer of an electron from the FeIII
ion to oxygen, resulting in the MnIV/FeIV state [96].
The modeling also suggests that the barrier for oxygen
cleavage by the Mn/Fe cofactor is some 3–4 kcal mol-1
lower than for the Fe/Fe cofactor, resulting from the higher
Fig. 4 Comparison of the oxygen activation and reaction mechanism of a R2a, b1 R2c and b2 R2lox. Transition states of metal cofactors
encircled in a dotted pattern are based on computational studies and have not been experimentally observed
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stability of MnIV compared to FeIV (Fig. 5) [96]. This
would imply that oxygen cleavage is significantly faster
with the heterodinuclear cofactor. Notably, these calculated
barriers are for formation of the IV/IV state. The calcula-
tions do not take injection of an external electron into
account, which occurs in R2c (but presumably not in
R2lox, see below) and would influence the experimentally
observed rates. Oxygen cleavage by an Mn/Mn center is
predicted to have a very high barrier, mainly due to the
stability of the peroxo species (Fig. 5) [96]. The calculated
energy profiles suggest that MnIII/FeIII-peroxo and MnIII/
MnIII-peroxo species can be formed; however, to date no
peroxo species has been experimentally observed in R2c or
R2lox.
Following complete O2 reduction the Mn
IV/FeIV metal
center in R2c undergoes a one-electron reduction resulting
in the MnIV/FeIII active state of the protein. Similar to the
injection of the ‘‘extra’’ electron during oxygen activation
in R2a, this reaction is proposed to proceed via W51, the
residue equivalent to W48 in E. coli R2a. Y222 in R2c, a
residue conserved among the R2c, but not R2lox proteins,
has also been shown to mediate this reaction [57, 113].
Together the data suggest a two-step mechanism via Y222
and W51 for the one-electron reduction of the MnIV/FeIV
intermediate in R2c.
The active MnIV/FeIII state has been characterized as an
antiferromagnetically coupled MnIV (S = 3/2)–FeIII
(S = 5/2) cofactor, resulting in a S = 1 (EPR silent)
ground state [52, 117]. It was also recently studied using a
combination of nuclear resonance vibrational spectroscopy,
absorption/circular dichroism/magnetic CD/variable tem-
perature, variable field MCD spectroscopies, along with
time-dependent DFT [118]. The results suggest the active
cofactor to be a l-oxo, l-hydroxo-bridged metal center
with a terminal hydroxo ligand residing on the MnIV. The
hydroxo ligand provides a high proton affinity site on
MnIV, suggested to aid radical transfer between the R2 and
R1 subunits.
R2c utilizes the MnIV/FeIII oxidation state in place of the
tyrosyl radical to activate the RNR R1 catalytic subunit
[52, 91, 113]. Calculations suggest that the radical equiv-
alent MnIV/FeIII redox state in R2c is an equally strong
oxidant as the tyrosyl radical in E. coli R2a [119], so the
redox potential of the MnIV/FeIII state is likely commen-
surate with that of the active site cysteinyl radical in the R1
subunit. The heterodinuclear cofactor may thus represent a
pure bioinorganic solution to produce a metal-centered
radical-equivalent state allowing reversible radical transfer
which the FeIV/FeIII center would probably not allow as it
would be too strong an oxidant.
R2lox, unlike R2a and R2c, performs a two-electron
oxidation reaction, similar to BMMs. sMMO, for example,
uses an oxygen activated di-iron metal center to perform
the two-electron hydroxylation of methane [31, 34]. R2lox
is capable of using the Mn/Fe center for the same type of
reaction: the MnII/FeII site catalyzes formation of an
unprecedented tyrosine-valine ether crosslink upon oxygen
activation [24, 28]. This reaction is formally a 2-electron
oxidation with the removal of 2 protons. Theoretical
modeling of this reaction suggests that the MnIV/FeIV state,
generated by oxygen cleavage analogous to R2c, oxidizes
Y162 to a tyrosyl radical, reducing FeIV to FeIII. This
radical is then transferred to V72, creating a valyl radical
intermediate. A second electron is subsequently transferred
to MnIV from V72, producing the tertiary valine carbo-
cation V72?. This is followed by a nucleophilic attack of
the Y162 phenolic oxygen on the Cb of V72?, thereby
forming the crosslink and leaving the cofactor in the
observed MnIII/FeIII state (Fig. 6) [28]. Using time-
resolved spectroscopic studies it will be possible to probe
this proposed mechanism experimentally.
The physiological function of R2lox proteins is to date
unknown. Modeling of the crosslink formation reaction
suggests that from the valine carbocation state, desaturation
of the valine is also possible. Therefore, it was proposed
that R2lox may function as a desaturase, performing ty-
rosyl radical mediated two-electron desaturations of bound
substrates [28]. R2lox proteins have a conserved tyrosine
that lines the ligand-binding cavity [57]. This residue
(Y175 in G. kaustophilus R2lox homologue 1) is posi-
tioned at a similar (*5 A˚) distance from the metal site as
Fig. 5 Calculated energy profiles of oxygen cleavage in R2c with
different combinations of metals, adapted from [96]
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Y162, as well as the radical harboring tyrosine in class Ia
R2 proteins, and may be involved in a substrate oxidation
reaction, analogous to Y162 in the crosslink formation.
Theoretical comparison of potential two-electron chemistry
performed by the Mn/Fe heterodimer and the Fe homodi-
mer suggests that the redox potential of the MnIV/FeIV site
is about 7 kcal mol-1 lower than that of an FeIV/FeIV site.
While this is likely not enough to oxidize methane to
methanol, it suggests that the MnIV/FeIV site can function
as an oxidase for larger exergonically bound substrates
[120].
Cofactor maturation
As detailed above, when crystals of R2lox are soaked with a
large excess of MnII and FeII in equal concentrations in the
absence of oxygen, site 1 is non-specific, binding equal
amounts of Mn and Fe, while site 2 binds mainly Fe.
Interestingly, however, in the presence of oxygen only Mn
is observed in site 1, while site 2 still contains mostly Fe
[28]. Based on computational data indicating that the oxy-
gen activation reaction (formation of the IV/IV state) is
significantly faster with the Mn/Fe than with the Fe/Fe
cofactor [96], we proposed a model for enrichment of the
Mn/Fe cluster through oxygen activation (Fig. 3). Metal
ions are labile bound in the two sites as long as the cofactor
remains reduced and can, therefore, likely exchange until
oxygen activation ‘‘fixes’’ the oxidized metal ion complex
in the binding site [95]. If metal exchange is fast compared
to oxygen activation, oxygen activation will preferentially
‘‘trap’’ the heterodinuclear cofactor over the di-iron center.
This model predicts that if metal ions are added in low or no
excess over binding sites, the Mn/Fe cluster will not be
significantly enriched, and the same percentage of Mn/Fe
centers will be obtained in the absence or presence of
oxygen. This was indeed found to be the case in EPR
samples of R2lox reconstituted in this manner [28]. While
the model remains to be thoroughly tested, these data
indicate that cofactor assembly in R2lox is controlled
thermodynamically, through metal-binding preferences,
and kinetically, through reactive differences between the
different metals. The efficiency of formation of the mixed-
metal cluster, therefore, depends not only on the accessi-
bility of the metal ions, but also on the rate of metal
exchange relative to the rate of oxygen binding, suggesting
that cofactor assembly in vivo might be regulated by con-
trolled delivery of either metal ions or oxygen to the protein.
Such cofactor maturation through oxygen activation has
not been described for R2c, but would also not be neces-
sary if, as proposed, cofactor assembly is entirely ther-
modynamically controlled by the apo protein structure
[56]. It should be noted that this thermodynamically con-
trolled assembly mechanism can only function if equilib-
rium is reached before oxygen activation, i.e., if kinetic
effects are excluded. The effect of oxygen on metal load-
ing/specificity in R2c has not been thoroughly investigated
to date. However, using aerobic sequential loading
schemes, a significant percentage of Fe/Fe cofactors was
formed even if Fe was added substoichiometrically [55,
94]. A direct competition experiment analogous to that
performed with R2lox would be very informative to further
elucidate the mechanism of cofactor assembly in R2c. It is
at this point not possible to exclude that similar results as
for R2lox would be obtained, although it would be
expected that both the rate of oxygen activation (see above)
and the rate of metal exchange in R2c and R2lox differ.
R2c has two preformed metal coordination positions, while
in R2lox site 1 is structurally dynamic and becomes
ordered only upon metal binding. Moreover, whereas in
R2c the active site is buried deep within the protein and
isolated from solvent [51, 56], R2lox proteins have a large
ligand-binding channel leading from the protein surface to
the active site [24, 28]. In the outer ligand sphere, residue
F197 of R2c is positioned between the two metal sites and
was proposed to prevent cooperativity between them [51].
In R2lox this residue is replaced by an alanine (A171).
Several such substitutions of large for small side chains
generate the ligand-binding channel in R2lox [24, 57]. A
phenylalanine in place of A171 would indeed block ligand
binding (Fig. 7). Therefore, the metal-binding sites are
more accessible in R2lox than in R2c. It appears likely that
the exchange rate for metals bound in R2c is lower than in
R2lox, while oxygen activation is faster due to injection of
Fig. 6 The proposed reaction mechanism for the tyrosine–valine ether crosslink formation observed in R2lox, based on theoretical modeling,
adapted from [28]
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an external electron, and the heterodinuclear cluster would
not be significantly enriched in R2c upon oxygen activa-
tion. Hence, differences in the cofactor assembly mecha-
nisms might have evolved along with, or even because of,
the structural and functional changes of these two enzyme
systems.
In summary, currently available data suggest that in
R2c, both Mn and Fe can bind in both sites, and a pref-
erence of FeII for site 2 drives formation of the MnII/FeII
cluster rather than the FeII/MnII cluster provided that Fe is
substoichiometric. In R2lox, on the other hand, it appears
that Mn preferentially binds in site 1, while Fe can bind in
both sites, and metal exchange in site 1 coupled with a
faster oxygen activation rate of the heterodinuclear cluster
drives formation of the oxidized Mn/Fe rather than the Fe/
Fe center (Fig. 3). In other words, in R2c Fe is enriched in
site 2 through thermodynamic effects, while in R2lox Mn is
enriched at site 1 through kinetic effects, in both cases
leading to formation of a heterodinuclear Mn/Fe cluster
with the Mn ion in site 1.
The structural basis for metal specificity
With more and more high-resolution structures of R2 and
R2-like proteins becoming available, it is growing
increasingly clear that there is no simple explanation for
the differential metal preferences these proteins display.
One would like to be able to point at a certain amino acid
residue or combination of residues as the basis for speci-
ficity, but the situation appears to be much more compli-
cated. Notably, the tempting conclusion that the identity of
the N-terminal metal ligand is responsible for the metal
specificity of site 1 does not hold up. This residue is an
aspartate in the di-iron class Ia and di-iron or di-manganese
class Ib R2 proteins, but a glutamate in the Mn/Fe proteins,
as well as the di-iron-binding BMMs (Fig. 1). As men-
tioned above, there is large structural flexibility in the
metal-binding sites, and some proteins are observed having
different metal ions bound, but with nearly identical active
site geometries (Fig. 1). Nevertheless, certain differences
which may be meaningful can be observed.
The geometries of the primary coordination spheres are
nearly identical in R2c and R2lox, both in the reduced and
the oxidized state (Fig. 7) [24, 28, 51, 56]. It should be
noted, however, that the oxidized state structure of R2c was
obtained with a di-iron cofactor. Structures of the oxidized
Mn/Fe-bound state of R2c have to date only been obtained
with mixed or substoichiometric metal loading and are
inconclusive [54, 55]. The most marked difference between
R2c and R2lox is that in R2lox a fatty acid ligand bridges
the metal ions in place of the hydroxo bridge of R2c. The
oxygen-derived bridging ligand present in the oxidized
state is an oxo anion in R2c, whereas it is a hydroxo anion
in R2lox [28, 51, 56, 118]. It must be presumed that the
particular copurifying fatty acid ligand in R2lox is an
artifact from heterologous overproduction, a compound
which likely bears similarity to a natural substrate, but is
not turned over and released from the protein. During a
normal oxygen activation reaction, an exogenous substrate
will likely not directly coordinate the metal ions at all
times, as it would require that protein-derived metal
ligands are displaced to allow for oxygen binding [28, 96].
The reaction intermediates might therefore display very
similar active site configurations as in R2c.
In both systems, both sites have distorted octahedral
coordination spheres, with the distortion being more pro-
nounced at site 2. MnII prefers perfect octahedral coordi-
nation geometries, whereas FeII displays a minor Jahn–
Teller effect, so that the geometry of site 2 is perhaps more
favorable towards Fe binding. The comparison with other
di-metal-carboxylate proteins reveals that both metal-
binding sites generally have distorted coordination spheres,
and the distortion is generally stronger in site 2. Interest-
ingly though, the iron-binding sites tend to be more dis-
torted than manganese-binding sites (Fig. 1).
Fig. 7 Structural comparison of
R2c and R2lox. a Superposition
of the reduced Mn/Fe-bound
states of R2lox (4HR4 [28]) and
R2c (4M1I [56]).
b Superposition of the oxidized
Mn/Fe-bound state of R2lox
(4HR0 [28]) and the oxidized
Fe/Fe-bound state of R2c (SYY
[51]). Amino acid residues of
R2lox are shown in cyan, the
fatty acid ligand in blue, and Mn
and Fe as purple and orange
spheres, respectively, while R2c
is shown in gray
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Another notable difference between the two sites in the
Mn/Fe proteins is that one of the metal ligands in site 1 is
water, perhaps lending more geometrical flexibility to this
site compared to site 2, which has only protein ligands in
the reduced state. This greater flexibility might allow site 1
to accommodate both Mn and Fe, while site 2 prefers Fe.
However, BMMs also have a water ligand in site 1 (Fig. 1)
[121, 122], yet are found to function with a di-iron cofactor
[123]. In short, as stated at the beginning of this section, the
case is clearly quite complicated, and we are yet far from
resolving how structure directs metal specificity, although
we can at this point firmly say that it does.
Conclusions
In R2c the Mn/Fe cofactor is assembled efficiently only if
Fe is present in substoichiometric amounts. This proposal
is in line with the speculation that the Mn/Fe cofactor may
be an adaptation to iron limiting conditions [56]. However,
R2c is only highly active with a mixed-metal cofactor [52,
53], and, therefore, organisms containing only a class Ic
RNR would have to always live under iron-limiting con-
ditions to have an efficiently assembled R2c subunit. We
know too little about the general cellular metal status of
most organisms to be able to say whether this is indeed the
case. This also relates to the question why the heterodi-
nuclear cofactor evolved. One hypothesis regarding its use
in R2c is that the active MnIV/FeIII state is less sensitive
than the tyrosyl radical to some radical scavengers such as
nitric oxide produced by the immune system of the host
[51]. This would be consistent with the observation that
these enzymes are primarily found among extremophiles
and pathogens that reside in particularly hostile environ-
ments [57]. It also finds support in that the active state in
R2c is stable to incubation with hydrogen peroxide and that
the active MnIV/FeIII state is even efficiently assembled by
incubation of reduced forms of the protein with hydrogen
peroxide [94] (Fig. 4).
To date it has not been shown that any R2c or R2lox
protein indeed binds a Mn/Fe cluster in vivo. Given
available data, however, this seems likely. In the case of
R2c the protein is only highly active with the heterodinu-
clear cofactor [52, 53]. For R2lox the case is less clear cut,
at least as long as its in vivo activity remains unknown. The
di-iron cofactor of BMMs catalyzes two-electron oxida-
tions from the IV/IV state, and hence it appears likely that
R2lox may function with both a Mn/Fe or a Fe/Fe cofactor.
The rationale for employing the more complex heterodi-
nuclear cofactor in this case could then be the greater
stability of its high valent state [120]. It is also possible that
the oxidation potential of the MnIV/FeIV state in R2lox is
commensurate with the intended substrate, thus reducing
the risk of detrimental side reactions that may occur with
the more reactive FeIV/FeIV cofactor. This reasoning is thus
partly analogous to the balancing of the MnIV/FeIII state in
R2c with the active site cysteinyl radical in the R1 subunit.
Alternatively, R2lox might utilize either a Mn/Fe or a
di-iron cofactor depending on the cellular metal status. In
contrast, R2c has to be very selective because there is no
tolerance for any other than the Mn/Fe cofactor. We,
therefore, speculate that the different chemistry the two
systems perform may reflect on their cofactor assembly
mechanisms.
As discussed above, the cellular environment influences
metal loading of proteins by providing the basis for metal
availability, alternate chelating groups, and potential metal
chaperones. However, available data show that the R2c and
R2lox proteins exhibit intrinsic metal specificity in vitro,
allowing them to discriminate between Mn and Fe and
promote formation of the correctly assembled heterodinu-
clear cofactor. Although a definitive structural or chemical
answer as to how is still elusive, it is interesting to note that
it appears that both the thermodynamics of metal binding
and the kinetics of oxygen activation likely play a role in
reaching this specificity.
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